Literature DB >> 18415709

Expression of p21(waf1/cip1), p27 (kip1), p63 and androgen receptor in low and high Gleason score prostate cancer.

Imre Romics1, Gergely Bánfi, Eszter Székely, Tibor Krenács, Béla Szende.   

Abstract

The aim of this study was to investigate the expression of p21(waf1/cip1), p27(kip1), p63 and androgen receptor proteins in relation to serum prostate specific antigen levels in low and high Gleason score prostate cancers. Biopsies of patients suffering from prostate adenocarcinoma of low (3 + 3 to 3 + 4) and high (5 + 4 to 5 + 5) Gleason scores (13 cases each group) were immunostained for positive regulators of cell cycle control (p21(waf1/cip1) and p27(kip1)), and essential markers of normal prostate gland ontogeny (p63) and growth (androgen receptor) to find differentially expressed markers of malignant progression. Serum prostate specific antigen levels were also monitored at the time of biopsy and following anti-androgen therapy. All cases except one in each group were androgen receptor positive. P63 and p21(waf1/cip1) proteins detected in normal basal cell nuclei were lost in all but one studied tumors respectively. P27(kip1) protein, however, was detected in all low Gleason score prostate cancers, but it was found in only 7/13 high score cases. Prostate specific antigen levels, either pre- or post-treatment, did not show strict correlation with the p27(kip1) results. The low to high grade dedifferentiation of prostate adenocarcinoma is accompanied with the down-regulation of p27(kip1) protein, which may be an important molecular sign of the lost cell cycle control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18415709     DOI: 10.1007/s12253-008-9042-z

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  22 in total

1.  Repeated biopsies in evaluation of therapeutic effects in prostate carcinoma.

Authors:  B Szende; I Romics; K Minik; J Szabó; I Torda; S Lovász; L Szomor; L Tóth; M Bély; T Kerényi; K Bartók; A Végh
Journal:  Prostate       Date:  2001-10-01       Impact factor: 4.104

Review 2.  Genes differentially expressed in prostate cancer.

Authors:  I E Eder; J Bektic; P Haag; G Bartsch; H Klocker
Journal:  BJU Int       Date:  2004-05       Impact factor: 5.588

3.  Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer.

Authors:  Katie L Meehan; John W Holland; Hugh J S Dawkins
Journal:  Prostate       Date:  2002-01-01       Impact factor: 4.104

4.  Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27.

Authors:  Y W Zhang; I Morita; M Ikeda; K W Ma; S Murota
Journal:  Oncogene       Date:  2001-07-12       Impact factor: 9.867

5.  Growth inhibition in G(1) and altered expression of cyclin D1 and p27(kip-1 )after forced connexin expression in lung and liver carcinoma cells.

Authors:  L Koffler; S Roshong; I Kyu Park; K Cesen-Cummings; D C Thompson; L D Dwyer-Nield; P Rice; C Mamay; A M Malkinson; R J Ruch
Journal:  J Cell Biochem       Date:  2000-09-07       Impact factor: 4.429

6.  Detection of differentially expressed genes in prostate cancer by combining suppression subtractive hybridization and cDNA library array.

Authors:  K P Porkka; T Visakorpi
Journal:  J Pathol       Date:  2001-01       Impact factor: 7.996

Review 7.  Androgen regulation of programmed death of normal and malignant prostatic cells.

Authors:  J T Isaacs; P I Lundmo; R Berges; P Martikainen; N Kyprianou; H F English
Journal:  J Androl       Date:  1992 Nov-Dec

8.  Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.

Authors:  Y Guo; G N Sklar; A Borkowski; N Kyprianou
Journal:  Clin Cancer Res       Date:  1997-12       Impact factor: 12.531

9.  Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.

Authors:  G B Baretton; U Klenk; J Diebold; N Schmeller; U Löhrs
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

10.  Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients.

Authors:  M Kuczyk; S Machtens; K Hradil; J Schubach; W Christian; R Knüchel; J Hartmann; C Bokemeyer; U Jonas; J Serth
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

View more
  4 in total

Review 1.  The AR dependent cell cycle: mechanisms and cancer relevance.

Authors:  Matthew J Schiewer; Michael A Augello; Karen E Knudsen
Journal:  Mol Cell Endocrinol       Date:  2011-07-12       Impact factor: 4.102

2.  Changes of protein expression in prostate cancer having lost its androgen sensitivity.

Authors:  Gergely Bánfi; Ivett Teleki; Péter Nyirády; Attila Keszthelyi; Imre Romics; Attila Fintha; Tibor Krenács; Béla Szende
Journal:  Int Urol Nephrol       Date:  2015-05-08       Impact factor: 2.370

3.  P21 and p27 Immunoexpression in Upper Urinary Tract Urothelial Carcinomas.

Authors:  Banu Sarsik; Basak Doganavsargil; Adnan Simsir; Ayse Yazici; Burcin Pehlivanoglu; Cag Cal; Sait Sen
Journal:  Pathol Oncol Res       Date:  2016-05-24       Impact factor: 3.201

4.  Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis.

Authors:  Sajad A War; Ujendra Kumar
Journal:  J Mol Signal       Date:  2012-05-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.